Jasper Therapeutics is trading at $0.57, down -7.74% in after-hours trading; no clear company-specific announcement or late-breaking catalyst was identified for September 18, 2026.
- Recent coverage focused on executive appointments and an H.C. Wainwright presentation outlining cash resources and clinical catalysts, rather than a new negative event.
- Broader markets were generally positive, so the decline does not clearly track overall market sentiment.